Long-term Outcome of Prophylactic Thyroidectomy in Children Carrying RET Germline Mutations
Overview
Affiliations
Background: A comprehensive assessment has not been undertaken of long-term outcomes in children carrying germline RET mutations and undergoing prophylactic thyroidectomy with the aim of preventing medullary thyroid cancer (MTC).
Methods: A retrospective outcome study (1994-2017) of prophylactic thyroidectomy in children, with and without central node dissection, was performed at a tertiary surgical centre.
Results: Some 167 children underwent prophylactic thyroidectomy, 109 without and 58 with concomitant central node dissection. In the highest-risk mutational category, MTC was found in five of six children (83 per cent) aged 3 years or less. In the high-risk category, MTC was present in six of 20 children (30 per cent) aged 3 years or less, 16 of 36 (44 per cent) aged 4-6 years, and 11 of 16 (69 per cent) aged 7-12 years (P = 0·081). In the moderate-risk category, MTC was seen in one of nine children (11 per cent) aged 3 years or less, one of 26 (4 per cent) aged 4-6 years, three of 26 (12 per cent) aged 7-12 years, and seven of 16 (44 per cent) aged 13-18 years (P = 0·006). Postoperative hypoparathyroidism was more frequent in older children (32 per cent in the oldest age group versus 3 per cent in the youngest; P = 0·002), whether or not central node dissection was carried out. Three children developed recurrent laryngeal nerve palsy; all had undergone central node dissection (P = 0·040). All complications resolved within 6 months. Postoperative normalization of calcitonin serum levels was achieved in 114 (99·1 per cent) of 115 children with raised preoperative values. No residual structural disease or recurrence was observed.
Conclusion: Early prophylactic thyroidectomy is a viable surgical concept in experienced hands, sparing older children the postoperative morbidity associated with delayed neck surgery.
Zhang Y, Zheng W, Zhou S, Gu J, Yu Q, Zhu Y Cell Commun Signal. 2024; 22(1):460.
PMID: 39342195 PMC: 11439284. DOI: 10.1186/s12964-024-01837-x.
Dralle H, Weber F, Lorenz K, Machens A Chirurgie (Heidelb). 2024; 95(8):638-650.
PMID: 38806713 PMC: 11286710. DOI: 10.1007/s00104-024-02105-x.
[Hereditary medullary thyroid cancer].
Fendrich V, Zahn A Chirurgie (Heidelb). 2023; 94(5):393-399.
PMID: 36799965 DOI: 10.1007/s00104-023-01824-x.
Torresan F, Censi S, Pennelli G, Galuppini F, Mian C, Iacobone M Cancers (Basel). 2022; 14(24).
PMID: 36551711 PMC: 9776584. DOI: 10.3390/cancers14246226.
Machens A, Lorenz K, Huessler E, Stang A, Weber F, Dralle H Endocrine. 2022; 80(1):100-110.
PMID: 36456885 PMC: 9715418. DOI: 10.1007/s12020-022-03273-8.